MyFinsight
Home
Blog
About
Marketable securities
(note 5)
$811,159K
(130.34%↑ Y/Y)
Cash and cash
equivalents
$119,527K
(-11.71%↓ Y/Y)
Prepaid expenses and
other current assets
$13,553K
(16.74%↑ Y/Y)
Other receivables
$1,629K
(48.50%↑ Y/Y)
Total current assets
$945,868K
(89.08%↑ Y/Y)
Marketable securities,
long-term (note 5)
$314,411K
(129.00%↑ Y/Y)
Deferred tax assets
$14,361K
(29.98%↑ Y/Y)
Prepaid expenses,
long-term
$7,973K
(-13.22%↓ Y/Y)
Property, plant and
equipment, net
$7,774K
(-15.55%↓ Y/Y)
Operating lease
right-of-use asset, net (note...
$5,385K
(-26.13%↓ Y/Y)
Total assets
$1,295,772K
(92.17%↑ Y/Y)
Total liabilities and
shareholders equity
$1,295,772K
(92.17%↑ Y/Y)
Total shareholders'
equity
$1,242,396K
(95.97%↑ Y/Y)
Total liabilities
$53,376K
(32.44%↑ Y/Y)
Accumulated deficit
-$1,458,418K
(-39.00%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$2,656K
(-2450.44%↓ Y/Y)
Common shares, without
par value unlimited...
$2,426,619K
(65.17%↑ Y/Y)
Total current
liabilities
$45,009K
(36.20%↑ Y/Y)
Operating lease
liability, long-term (note...
$5,080K
(-29.99%↓ Y/Y)
Other liabilities,
long-term
$3,287K
Additional paid-in capital
$276,851K
(29.43%↑ Y/Y)
Accounts payable and
accrued liabilities...
$43,671K
(38.25%↑ Y/Y)
Operating lease liability
(note 6)
$1,338K
(-8.29%↓ Y/Y)
Back
Back
Balance Sheet
logo_icon_teal_2280px-svg
Xenon Pharmaceuticals Inc. (XENE)
logo_icon_teal_2280px-svg
source: myfinsight.com
Xenon Pharmaceuticals Inc. (XENE)